H-8 (hydrochloride) (Synonyms: Protein Kinase Inhibitor H-8) |
| Catalog No.GC12799 |
H-8 (dihydrochloride) is a cell-permeable, reversible and ATP-competitive PKA inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 113276-94-1
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 113276-94-1 | SDF | |
| Synonyms | Protein Kinase Inhibitor H-8 | ||
| Chemical Name | N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide, dihydrochloride | ||
| Canonical SMILES | CNCCNS(C1=CC=CC2=CN=CC=C21)(=O)=O.Cl.Cl | ||
| Formula | C12H15N3O2S • 2HCl | M.Wt | 338.3 |
| Solubility | ≤20mg/ml in DMSO;20mg/ml in dimethyl formamide | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.956 mL | 14.7798 mL | 29.5596 mL |
| 5 mM | 0.5912 mL | 2.956 mL | 5.9119 mL |
| 10 mM | 0.2956 mL | 1.478 mL | 2.956 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GN10797 Tangeretin
- GC31290 3-Indolepropionic acid
- GC42709 Ac-LEVD-CHO (trifluoroacetate salt)
- GC13585 YM 26734
- GC10220 TAK-593
- GC44321 Nat-20(S)-yne
- GC32772 Triptorelin ([DTrp6]-LH-RH)
- GC38008 β-Zearalenol
- GC38305 Talc
- GC36981 PROTAC AR Degrader-4
- GC40256 p-APMSF (hydrochloride)
- GC31655 Cholera toxin (choleragen)
- GC17374 Pramiracetam
- GC31767 Peptide 401
- GC61665 Tetrahydroxyquinone monohydrate
- GC16500 [Lys5,MeLeu9,Nle10]-NKA(4-10)
- GC16049 AMI-193
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *